Answers are grounded in this paper and cite their sources.
This analysis reveals potential targets and pathways of Danggui Buxue Tang in renal anemia treatment, suggesting holistic therapeutic benefits.
Background: Danggui Buxue Tang (DBT) is a classical Chinese medicine formula that promotes Qi and generates blood. However, its targets and pathways in the treatment of renal anemia (RA) remain unclear. This study aimed to investigate the mechanisms of DBT in treating RA using network pharmacology and molecular docking methods. Methods: The active ingredients of DBT were screened using the Traditional Chinese Medicine Systems Pharmacology database. Targets for DBT and RA were obtained using the SwissTargetPrediction and GeneCard databases, respectively, and the intersection was the potential target. Protein-protein interaction (PPI) networks were constructed with the help of the STRING database and Cytoscape software. Gene ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment results were obtained using the David database. Cytoscape software was also utilized to map the drug-active ingredient-potential target network. Finally, AutoDock Vina was used for molecular docking, and the results were visualized using PyMOL software. Results: Twenty-two active ingredients and 125 potential targets were obtained. Core targets included Estrogen Receptor 1 (ESR1), Caspase 3 (CASP3), AKT1, Epidermal Growth Factor Receptor (EGFR), Mammalian Target Of Rapamycin (MTOR), and Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1). GO and KEGG enrichment analyses demonstrated that the potential targets were mainly involved in Adenosine TriPhosphate (ATP) binding and protein tyrosine kinase activity, regulating PI3K-Akt, phospholipase D, and FoxO signaling pathways. The molecular docking results showed that these core targets bind strongly to the active ingredients isomucronulatol, methylnissolin, isorhamnetin, kaempferol, quercetin, stigmasterol, and jaranol. Conclusion: DBT may act through multiple biological processes and signaling pathways in the treatment of RA. These data provide a theoretical basis for future experimental studies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: